AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16549839 — intervention group
Group type: EXPERIMENTAL
Intervention: CD146 expression
Number of subjects: 0
Study 16549839 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue analysis
Number of subjects: 0
Study 14680844 — intervention group
Group type: EXPERIMENTAL
Intervention: mtDNA variant at 16,189
Number of subjects: 268
Study 14680844 — intervention group
Group type: EXPERIMENTAL
Intervention: mtDNA abnormalities at 3243, 3316, and 15,927
Number of subjects: 268
Study 10720792 — intervention group
Group type: EXPERIMENTAL
Intervention: S. asper leaf extract
Number of subjects: 30
Study 10720792 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 30
Study 8788485 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 0.25 to 1.0 mg/kg, p.o.
Number of subjects: 6
Study 8788485 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA 0.5 to 0.75 mg/kg, p.o.
Number of subjects: 6
Study 8788485 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA higher doses (above 0.75 mg/kg)
Number of subjects: 6
Study 8788485 — intervention group
Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 6
Study 1555550 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 6
Study 1555550 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 6
Study 1555550 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine 50 mg
Number of subjects: 6
Study 3884806 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam, 20 mg OD
Number of subjects: 145
Study 3884806 — intervention group
Group type: COMPARATOR
Intervention: Enteric coated acetylsalicylic acid (EC ASA), 3.9‐5.2 g daily in divided doses
Number of subjects: 145
Study 31855907 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 3% hypertonic saline (HTS)
Number of subjects: 20
Study 31855907 — intervention group
Group type: COMPARATOR
Intervention: IV 3% hypertonic saline (HTS)
Number of subjects: 20
Study 29966211 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast squat exercise
Number of subjects: 38
Study 29966211 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast squat on unstable surface
Number of subjects: 38
Study 26628478 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib 1,250mg daily plus CapeOx
Number of subjects: 545
Study 26628478 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus CapeOx
Number of subjects: 545
Study 24878676 — intervention group
Group type: EXPERIMENTAL
Intervention: BPT plus ongoing routine clinical care (RCC)
Number of subjects: 83
Study 24878676 — intervention group
Group type: COMPARATOR
Intervention: RCC alone
Number of subjects: 83
Study 22943229 — intervention group
Group type: EXPERIMENTAL
Intervention: Floseal()
Number of subjects: 42
Study 20100188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 48
Study 20100188 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 48
Study 20100188 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 48
Study 18818415 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (PIO) therapy
Number of subjects: 66
Study 18818415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 15799733 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% gel
Number of subjects: 32
Study 15799733 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anaesthesia
Number of subjects: 32
Study 12410785 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 295
Study 12410785 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 295
Study 10430526 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelseal prostheses
Number of subjects: 25
Study 10430526 — intervention group
Group type: COMPARATOR
Intervention: Gelweave prostheses
Number of subjects: 25
Study 7588502 — intervention group
Group type: EXPERIMENTAL
Intervention: oat gum instant whip, 9 g beta‐glucan/day
Number of subjects: 14
Study 7588502 — intervention group
Group type: COMPARATOR
Intervention: placebo instant whip
Number of subjects: 14
Study 1688970 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicardipine (N)
Number of subjects: 16
Study 1688970 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 16
Study 634316 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroprusside plus hydroxocobalamin
Number of subjects: 0
Study 634316 — intervention group
Group type: COMPARATOR
Intervention: Nitroprusside alone
Number of subjects: 0
Study 31486694 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical triamcinolone acetonide‐loaded liposomal formulation (TA‐LF) 2 mg/mL (0.2%) for 21 days postoperatively
Number of subjects: 56
Study 31486694 — intervention group
Group type: COMPARATOR
Intervention: Combined therapy with prednisolone 1% and nepafenac 0.1% for 21 days postoperatively
Number of subjects: 56
Study 31486694 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 56
Study 31486694 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical triamcinolone acetonide‐loaded liposomal formulation (TA‐LF)
Number of subjects: 56
Study 28276950 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual care therapy
Number of subjects: 0
Study 28276950 — intervention group
Group type: COMPARATOR
Intervention: Control group (no spiritual care)
Number of subjects: 0
Study 26231885 — intervention group
Group type: EXPERIMENTAL
Intervention: LCZ696 (sacubitril-valsartan)
Number of subjects: 8399
Study 26231885 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study 23382191 — intervention group
Group type: EXPERIMENTAL
Intervention: Metreleptin administration
Number of subjects: 0
Study 20883582 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 536
Study 20883582 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 536
Study 19019768 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue-stained group
Number of subjects: 60
Study 19019768 — intervention group
Group type: COMPARATOR
Intervention: Unstained group
Number of subjects: 60
Study 15919229 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical joint position error (JPE)
Number of subjects: 140
Study 15919229 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth pursuit neck torsion test (SPNT)
Number of subjects: 140
Study 15919229 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotation cervical JPE score
Number of subjects: 140
Study 12505557 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliant use of CPAP at 3 months
Number of subjects: 12
Study 12505557 — intervention group
Group type: COMPARATOR
Intervention: Noncompliant use of CPAP
Number of subjects: 12
Study 12505557 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline attention measures
Number of subjects: 12
Study 10758695 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (group A)
Number of subjects: 45
Study 10758695 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone (group B)
Number of subjects: 45
Study 10758695 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (group C)
Number of subjects: 45
Study 8899080 — intervention group
Group type: EXPERIMENTAL
Intervention: Butyrate enemas (60 mL of 80 mM sodium butyrate)
Number of subjects: 38
Study 8899080 — intervention group
Group type: COMPARATOR
Intervention: Saline/placebo enemas
Number of subjects: 38
Study 1799912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime 500 mg
Number of subjects: 142
Study 1799912 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone 250 mg
Number of subjects: 142
Study 6351363 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu 220C
Number of subjects: 1060
Study 6351363 — intervention group
Group type: EXPERIMENTAL
Intervention: Lippes Loop D
Number of subjects: 1060
Study 6351363 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper 7
Number of subjects: 1060
Study 6351363 — intervention group
Group type: COMPARATOR
Intervention: Control (immediate insertion after delivery of placenta)
Number of subjects: 1060
Study 29358531 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple child meal (SCM; n = 8)
Number of subjects: 16
Study 29358531 — intervention group
Group type: COMPARATOR
Intervention: Hearty child meal (HCM; n = 8)
Number of subjects: 16
Study 29358531 — intervention group
Group type: COMPARATOR
Intervention: Both groups (SCM and HCM)
Number of subjects: 16
Study 27023901 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-sitting group (seated out of bed within one calendar day after stroke onset)
Number of subjects: 138
Study 27023901 — intervention group
Group type: COMPARATOR
Intervention: Progressively-sitting group (seated out of bed on the third calendar day after stroke onset)
Number of subjects: 138
Study 27023901 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-sitting group
Number of subjects: 138
Study 27023901 — intervention group
Group type: COMPARATOR
Intervention: Progressively-sitting group
Number of subjects: 138
Study 23364318 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based AOM Family Intervention
Number of subjects: 131
Study 23364318 — intervention group
Group type: COMPARATOR
Intervention: Workbook-based AOM Family Intervention
Number of subjects: 131
Study 24349257 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based e-learning (GbEl)
Number of subjects: 145
Study 24349257 — intervention group
Group type: COMPARATOR
Intervention: Conventional script-based instruction (script group)
Number of subjects: 145
Study 21494170 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive training model (group A)
Number of subjects: 1282
Study 21494170 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture-based training model (group B)
Number of subjects: 1282
Study 21494170 — intervention group
Group type: EXPERIMENTAL
Intervention: Video instruction training model (group C)
Number of subjects: 1282
Study 18313556 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential designs (group sequential designs, boundaries designs, adaptive designs)
Number of subjects: 0
Study 17201235 — intervention group
Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide instillation
Number of subjects: 24
Study 17201235 — intervention group
Group type: COMPARATOR
Intervention: Topical administration of betamethasone
Number of subjects: 24
Study 14690186 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous SonoVue contrast echocardiography
Number of subjects: 11
Study 14690186 — intervention group
Group type: COMPARATOR
Intervention: Intermittent harmonic B-mode imaging
Number of subjects: 11
Study 11310114 — intervention group
Group type: EXPERIMENTAL
Intervention: 633 nm laser source with a 3 kHz bandwidth filter using a probe with a 500 microns fibre separation placed 2‐3 mm from the gingival margin
Number of subjects: 10
Study 11310114 — intervention group
Group type: COMPARATOR
Intervention: non-vital tooth
Number of subjects: 10
Study 8830396 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU)
Number of subjects: 32
Study 1638306 — intervention group
Group type: EXPERIMENTAL
Intervention: Minaprine (200 mg daily)
Number of subjects: 144
Study 1638306 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (25-50 mg t.d.s.)
Number of subjects: 144
Study 1638306 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 144
Study 6701732 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid (RL)
Number of subjects: 46
Study 6701732 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid (5% ALB)
Number of subjects: 46
Study 29370407 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐coaching (automated program of 45 e‐mails over 3 months)
Number of subjects: 2478
Study 29370407 — intervention group
Group type: COMPARATOR
Intervention: booklet (PDF version of a smoking cessation booklet)
Number of subjects: 2478
Study 29370407 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐coaching (per-protocol sample)
Number of subjects: 2478
Study 29766294 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot (BR) juice (140 mL/day, containing 8 mmol of nitrate)
Number of subjects: 8
Study 29766294 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) juice (140 mL/day, containing 0.003 mmol of nitrate)
Number of subjects: 8
Study 29766294 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot (BR) juice
Number of subjects: 8
Study 29766294 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) juice
Number of subjects: 8
Study 26194850 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-Folic Acid (IFA)
Number of subjects: 1391
Study 26194850 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Micronutrients (MMN)
Number of subjects: 1391
Study 26194850 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-Based Nutrient Supplements (LNS)
Number of subjects: 1391
Study 26194850 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MMN to IFA
Number of subjects: 1391
Study 26194850 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LNS to IFA
Number of subjects: 1391
Study 24240632 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare/kindergarten attendees
Number of subjects: 277
Study 24240632 — intervention group
Group type: EXPERIMENTAL
Intervention: Swimming in public pools/spas in the current or previous week
Number of subjects: 277
Study 22978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Qianggu Granule (QGG)
Number of subjects: 90
Study 22978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacerein Capsule (DC)
Number of subjects: 90
Study 22978102 — intervention group
Group type: EXPERIMENTAL
Intervention: Qianggu Granule (QGG) + Diacerein Capsule (DC)
Number of subjects: 90
Study 20576731 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline in addition to systemic corticosteroids
Number of subjects: 205
Study 20576731 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 205
Study 17926797 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib malate (Sutent)
Number of subjects: 0
Study 17926797 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib tosylate (Nexavar)
Number of subjects: 0
Study 17926797 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (Avastin)/interferon alfa
Number of subjects: 0
Study 17926797 — intervention group
Group type: EXPERIMENTAL
Intervention: Temsirolimus (Torisel)
Number of subjects: 0
Study 17926797 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 0
Study 17926797 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib
Number of subjects: 0
Study 17926797 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 0
Study 16241976 — intervention group
Group type: EXPERIMENTAL
Intervention: Glatiramer acetate (GA) therapy
Number of subjects: 0
Study 12933923 — intervention group
Group type: EXPERIMENTAL
Intervention: IVMP with planned multidisciplinary team (MDT) care
Number of subjects: 40
Study 12933923 — intervention group
Group type: COMPARATOR
Intervention: IVMP with standard care
Number of subjects: 40
Study 10657819 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (10 tuck jumps 3 times weekly, jumping, hopping, and skipping incorporated into twice weekly physical education classes)
Number of subjects: 144
Study 10657819 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular physical education classes)
Number of subjects: 144
Study 8896159 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemaccel
Number of subjects: 20
Study 8896159 — intervention group
Group type: COMPARATOR
Intervention: human albumin
Number of subjects: 20
Study 1714532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron plus dexamethasone
Number of subjects: 31
Study 1714532 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron plus placebo
Number of subjects: 31
Study 1714532 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (ondansetron plus dexamethasone)
Number of subjects: 31
Study 6357270 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly cardiotocography (antenatal fetal heart rate monitoring)
Number of subjects: 539
Study 6357270 — intervention group
Group type: EXPERIMENTAL
Intervention: Abnormal antenatal fetal heart rate traces
Number of subjects: 539
Study 6357270 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring
Number of subjects: 539
Study 30747010 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated physiotherapy programme
Number of subjects: 80
Study 30747010 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy programme
Number of subjects: 80
Study 29601344 — intervention group
Group type: EXPERIMENTAL
Intervention: I‐InTERACT (10‐14 sessions)
Number of subjects: 148
Study 29601344 — intervention group
Group type: EXPERIMENTAL
Intervention: Express (7 sessions)
Number of subjects: 148
Study 29601344 — intervention group
Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 148
Study 27655232 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 0
Study 27655232 — intervention group
Group type: COMPARATOR
Intervention: Stretch‐balance training
Number of subjects: 0
Study 27655232 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 0
Study 24485283 — intervention group
Group type: EXPERIMENTAL
Intervention: GET.ON Mood Enhancer Prevention training
Number of subjects: 406
Study 24485283 — intervention group
Group type: COMPARATOR
Intervention: Online-based psychoeducation on depression
Number of subjects: 406
Study 21808985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase (0.9 mg/kg)
Number of subjects: 12
Study 21808985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 19935100 — intervention group
Group type: EXPERIMENTAL
Intervention: Light resistance exercise (LRO) at 30% of 1RM with partial occlusion
Number of subjects: 7
Study 19935100 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate resistance exercise (MR) at 70% of 1RM with no occlusion
Number of subjects: 7
Study 19935100 — intervention group
Group type: COMPARATOR
Intervention: Partial occlusion without exercise (OO)
Number of subjects: 7
Study 17931240 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-gentamicin (260 mg gentamicin) sponges applied within the sternotomy before wound closure
Number of subjects: 2000
Study 17931240 — intervention group
Group type: COMPARATOR
Intervention: Intravenous isoxazolyl penicillin alone
Number of subjects: 2000
Study 17931240 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen-gentamicin (260 mg gentamicin) sponges
Number of subjects: 2000
Study 15536640 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg/day)
Number of subjects: 12
Study 15536640 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (loratadine 10 mg/day)
Number of subjects: 12
Study 11907500 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride, 1 mg/d
Number of subjects: 66
Study 11907500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 9468419 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible gastroscope
Number of subjects: 216
Study 9468419 — intervention group
Group type: COMPARATOR
Intervention: Bronchoscope
Number of subjects: 216
Study 7657952 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine therapy
Number of subjects: 0
Study 2093381 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (60 mg per day)
Number of subjects: 39
Study 2093381 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (40 mg per day)
Number of subjects: 39
Study 636560 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) or ASA-dipyridamole
Number of subjects: 90
Study 636560 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulants
Number of subjects: 90
Study 30468356 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape (KT) applied to the ankle and foot for a two-week period
Number of subjects: 42
Study 30468356 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Kinesio tape)
Number of subjects: 42
Study 28187751 — intervention group
Group type: EXPERIMENTAL
Intervention: simeprevir 75 mg once daily + TMC647055 450 mg once daily/ritonavir 30 mg once daily + ribavirin 1000-1200 mg/day (Panel 1)
Number of subjects: 70
Study 28187751 — intervention group
Group type: EXPERIMENTAL
Intervention: simeprevir 75 mg once daily + TMC647055 450 mg once daily/ritonavir 30 mg once daily + ribavirin 1000-1200 mg/day (Panel 2-Arm 1)
Number of subjects: 70
Study 28187751 — intervention group
Group type: COMPARATOR
Intervention: simeprevir 75 mg + TMC647055 450 mg/ritonavir 30 mg without ribavirin (Panel 2-Arm 2)
Number of subjects: 70
Study 28187751 — intervention group
Group type: EXPERIMENTAL
Intervention: simeprevir 75 mg + TMC647055 600 mg/ritonavir 50 mg with ribavirin (Panel 3-Arm 1)
Number of subjects: 70
Study 28187751 — intervention group
Group type: COMPARATOR
Intervention: simeprevir 75 mg + TMC647055 600 mg/ritonavir 50 mg without ribavirin (Panel 3-Arm 2)
Number of subjects: 70
Study 28187751 — intervention group
Group type: EXPERIMENTAL
Intervention: simeprevir 75 mg + TMC647055 450 mg/ritonavir 30 mg + JNJ-56914845 30 mg once daily (Panel 4-Arm 1)
Number of subjects: 70
Study 28187751 — intervention group
Group type: EXPERIMENTAL
Intervention: simeprevir 75 mg + TMC647055 450 mg/ritonavir 30 mg + JNJ-56914845 60 mg once daily (Panel 4-Arm 2)
Number of subjects: 70
Study 25525891 — intervention group
Group type: COMPARATOR
Intervention: Monovision
Number of subjects: 50
Study 25525891 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal lenses (Air Optix Aqua)
Number of subjects: 50
Study 25525891 — intervention group
Group type: EXPERIMENTAL
Intervention: Both corrections
Number of subjects: 50
Study 23694965 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary nitinol stent placement
Number of subjects: 246
Study 23694965 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal balloon angioplasty
Number of subjects: 246
Study 21199800 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, high-carbohydrate diet with intensive dietary counseling (target: 15% of calories from fat, 65% from carbohydrates)
Number of subjects: 4690
Study 21199800 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (standard dietary advice)
Number of subjects: 4690
Study 19767063 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative expression of ΔNp63α
Number of subjects: 56